Faced with skyrocketing costs for developing new drugs, researchers are looking at ways to repurpose older ones — and even some that failed in initial trials.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Basal–epithelial subpopulations underlie and predict chemotherapy resistance in triple-negative breast cancer
EMBO Molecular Medicine Open Access 13 March 2024
-
Oral intake of bucillamine, carvedilol, metformin, or phenformin does not protect against UVR-induced squamous cell carcinomas in hairless mice
Photochemical & Photobiological Sciences Open Access 09 February 2024
-
Large numbers of patients are needed to obtain additional approvals for new cancer drugs: A retrospective cohort study
Scientific Reports Open Access 26 September 2023
Access options
Subscribe to this journal
Receive 52 print issues and online access
$199.00 per year
only $3.83 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
Singh, N. et al. Nature Commun. http://dx.doi.org/10.1038/ncomms2320 (2013).
Singh, N. et al. Neuropsychopharmacology 41, 1768–1778 (2016).
Scannell, J. W., Blanckley, A., Boldon, H. & Warrington, B. Nature Rev. Drug Discov. 11, 191–200 (2012).
American Chemical Society. International Year of Chemistry 2011: Activities Report of the American Chemical Society (ACS, 2011); available at http://go.nature.com/1tbzmxn
Lekka, E., Deftereos, S. N., Persidis, A., Persidis, A. & Andronis, C. Drug Discov. Today Ther. Strateg. 8, 103–108 (2011).
Author information
Authors and Affiliations
Related links
Related links
Related links in Nature Research
Personalized medicine: Time for one-person trials 2015-Apr-29
Europe bets on drug discovery 2013-Feb-07
US translational-science centre gets under way 2012-Jan-10
Traditional drug-discovery model ripe for reform 2011-Mar-02
Related external links
National Center for Advancing Translational Sciences
Rights and permissions
About this article
Cite this article
Nosengo, N. Can you teach old drugs new tricks?. Nature 534, 314–316 (2016). https://doi.org/10.1038/534314a
Published:
Issue date:
DOI: https://doi.org/10.1038/534314a
This article is cited by
-
Basal–epithelial subpopulations underlie and predict chemotherapy resistance in triple-negative breast cancer
EMBO Molecular Medicine (2024)
-
Oral intake of bucillamine, carvedilol, metformin, or phenformin does not protect against UVR-induced squamous cell carcinomas in hairless mice
Photochemical & Photobiological Sciences (2024)
-
Synthesis and antiviral property of polysulfate-grafted maleimide-based enediynes
Medicinal Chemistry Research (2024)
-
Drug repurposing strategy part 1: from approved drugs to agri-bactericides leads
The Journal of Antibiotics (2023)
-
Repurposing of neprilysin inhibitor ‘sacubitrilat’ as an anti-cancer drug by modulating epigenetic and apoptotic regulators
Scientific Reports (2023)
